After the normalization of uric acid, it is necessary to clarify whether it is necessary to continue to take febuxostat according to the situation, including whether it is combined with gouty arthritis, gouty stone, chronic joint disease and other conditions. Febuxostat belongs to the clinically commonly used uric acid-lowering drugs, suitable for gout patients with hyperuricemia treatment, after active drug treatment, can effectively reduce uric acid levels, improve the patient’s clinical symptoms. When the uric acid level is normalized, you can choose whether to stop or continue the medication according to the patient’s condition. Gout and hyperuricemia patients blood uric acid control goals are: for simple hyperuricemia patients, it is recommended to lower blood uric acid long-term control below 420 μmol / L; for gout patients, it is recommended to long-term control below 360 μmol / L; for patients with gout stone, chronic joint disease, it is recommended to period control below 360 μmol / L. Therefore, when the blood uric acid level returns to normal, it is still necessary to consider whether to stop using the drug under the guidance of the doctor, and not to stop the drug without authorization to avoid the recurrence of the condition.